+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Premature Ejaculation Treatment Market by Treatment Type (Non Pharmacological, Pharmacological Systemic, Topical), End User (Clinics, Home Care, Hospitals), Dosage Form - Global Forecast 2025-2030- Product Image
Premature Ejaculation Treatment Market by Treatment Type (Non Pharmacological, Pharmacological Systemic, Topical), End User (Clinics, Home Care, Hospitals), Dosage Form - Global Forecast 2025-2030- Product Image
Sale

Premature Ejaculation Treatment Market by Treatment Type (Non Pharmacological, Pharmacological Systemic, Topical), End User (Clinics, Home Care, Hospitals), Dosage Form - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968711
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The premature ejaculation treatment market is evolving as industry leaders seek innovative approaches to improve patient outcomes while meeting demand for safe, accessible, and individualized therapies. Progressive developments across clinical protocols, digital health, and supply resilience continue to shape strategic priorities for stakeholders navigating this dynamic sector.

Market Snapshot: Premature Ejaculation Treatment Market Trends

The premature ejaculation treatment market grew from USD 3.86 billion in 2024 to USD 4.24 billion in 2025. It is expected to continue growing at a CAGR of 9.84%, reaching USD 6.78 billion by 2030. Market expansion is fueled by demand for advanced therapies, precise patient management, and enhanced reimbursement frameworks. Ongoing clinical advances and digital tools are opening new pathways for both established and emerging players.

Scope & Segmentation

  • Treatment Types: Behavioral therapy (including sensate focus and the start-stop technique), devices (such as constrictive rings and vibratory stimulation), systemic pharmacotherapy (phosphodiesterase inhibitors like sildenafil and tadalafil, selective serotonin reuptake inhibitors including dapoxetine, with off-label SSRIs such as fluoxetine, paroxetine, and sertraline), and topical anesthetics (lidocaine cream, lidocaine-prilocaine spray, prilocaine cream).
  • End-User Channels: Clinics with specialized sexual health units, home care options supported by telehealth, and hospitals integrating multidisciplinary approaches.
  • Dosage Forms: Creams, sprays, and tablets for tailored therapeutic regimens.
  • Regional Coverage: Americas (including major US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (featuring UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and additional nations), Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asia, and others).
  • Key Industry Players: Menarini Group, Teva Pharmaceuticals Industries Ltd., Cipla Limited, Lupin Limited, Sun Pharmaceutical Industries Ltd., Sandoz International GmbH, Panacea Biotec Ltd., Endo International plc, Reckitt Benckiser Group plc, Bayer AG.

Key Takeaways for Senior Decision-Makers

  • Comprehensive management now relies on integrating pharmacological, behavioral, and device-based strategies, improving both efficacy and patient adherence.
  • Digital health solutions—including mobile applications and telemedicine—are streamlining patient monitoring, expanding access, and supporting guided interventions for at-home care.
  • Regulatory alignment, especially across Europe and select Middle Eastern markets, is expediting the development and approval of advanced therapies.
  • Personalized medicine is enabling more targeted treatment regimens, driving higher rates of patient satisfaction and improved clinical outcomes.
  • Industry competition is increasing as pharmaceutical and device companies pursue strategic alliances, enhancing innovation pipelines and integrated therapy solutions.
  • Regionally tailored strategies are essential due to varying cultural, regulatory, and economic dynamics influencing adoption across global markets.

Tariff Impact on the Premature Ejaculation Treatment Market

US tariffs introduced in 2025 have led to notable shifts in the supply chain, impacting the cost and availability of imported devices and raw materials for topical therapies. Manufacturers are adapting with revised sourcing, localized production, and renegotiated supplier agreements. Consequently, healthcare providers are evaluating new models to balance affordability while sustaining innovation.

Methodology & Data Sources

This report employs a mixed-methods approach, combining interviews with leading clinicians, regulatory advisors, and procurement professionals with secondary research from scientific journals, guideline publications, marketplace data, and patent analysis. Continuous data triangulation and expert validation ensure the reliability and transparency of insights.

Why This Report Matters

  • Provides decision-makers with actionable strategies for personalized therapy development, competitive positioning, and operational resilience.
  • Enables forward-looking assessments of tariff impacts, digital health uptake, and regulatory pathways, all grounded in robust and validated research.
  • Empowers industry leaders to align with emerging trends and optimize investments for sustainable growth and improved patient outcomes.

Conclusion

The premature ejaculation treatment market is advancing through personalized medicine, digital innovations, and flexible go-to-market strategies. This report equips senior leaders with actionable intelligence to fortify competitive advantage amidst evolving industry dynamics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of digital therapeutics and smartphone apps for personalized premature ejaculation management
5.2. Rising adoption of off-label antidepressants and topical anesthetics in emerging markets
5.3. Expansion of telehealth platforms enabling discreet virtual consultations for premature ejaculation care
5.4. Surge in research on non-pharmacological interventions such as behavioral therapy and pelvic floor training
5.5. Development of novel fast-acting selective serotonin reuptake inhibitors designed for on-demand usage in PE treatment
5.6. Growing collaborations between pharmaceutical companies and digital health startups to deliver integrated PE solutions
5.7. Increasing patient preference for combination therapies integrating oral and topical formulations in PE management
5.8. Regulatory advancements streamlining approval pathways for innovative signal transduction pathway modifiers targeting PE
5.9. Market entry strategies focusing on cost-effective generics and biosimilars adoption in Asia-Pacific PE treatment market
5.10. Impact of direct-to-consumer telemedicine platforms on accessibility and adherence in premature ejaculation care
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Premature Ejaculation Treatment Market, by Treatment Type
8.1. Introduction
8.2. Non Pharmacological
8.2.1. Behavioral Therapy
8.2.1.1. Sensate Focus
8.2.1.2. Start Stop Technique
8.2.2. Devices
8.2.2.1. Constrictive Ring
8.2.2.2. Vibratory Stimulation
8.3. Pharmacological Systemic
8.3.1. Phosphodiesterase Inhibitors
8.3.1.1. Sildenafil
8.3.1.2. Tadalafil
8.3.2. Selective Serotonin Reuptake Inhibitors
8.3.2.1. Dapoxetine
8.3.2.2. Off Label Ssris
8.3.2.2.1. Fluoxetine
8.3.2.2.2. Paroxetine
8.3.2.2.3. Sertraline
8.4. Topical
8.4.1. Local Anesthetics
8.4.1.1. Lidocaine Cream
8.4.1.2. Lidocaine Prilocaine Spray
8.4.1.3. Prilocaine Cream
9. Premature Ejaculation Treatment Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Home Care
9.4. Hospitals
10. Premature Ejaculation Treatment Market, by Dosage Form
10.1. Introduction
10.2. Creams
10.3. Sprays
10.4. Tablets
11. Americas Premature Ejaculation Treatment Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Premature Ejaculation Treatment Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Premature Ejaculation Treatment Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Menarini Group
14.3.2. Teva Pharmaceuticals Industries Ltd.
14.3.3. Cipla Limited
14.3.4. Lupin Limited
14.3.5. Sun Pharmaceutical Industries Ltd.
14.3.6. Sandoz International GmbH
14.3.7. Panacea Biotec Ltd.
14.3.8. Endo International plc
14.3.9. Reckitt Benckiser Group plc
14.3.10. Bayer AG
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. PREMATURE EJACULATION TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. PREMATURE EJACULATION TREATMENT MARKET: RESEARCHAI
FIGURE 22. PREMATURE EJACULATION TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 23. PREMATURE EJACULATION TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 24. PREMATURE EJACULATION TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PREMATURE EJACULATION TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SENSATE FOCUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SENSATE FOCUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY START STOP TECHNIQUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY START STOP TECHNIQUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CONSTRICTIVE RING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CONSTRICTIVE RING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY VIBRATORY STIMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY VIBRATORY STIMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SILDENAFIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SILDENAFIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TADALAFIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TADALAFIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY FLUOXETINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY FLUOXETINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PAROXETINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PAROXETINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SERTRALINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SERTRALINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LIDOCAINE CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LIDOCAINE CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LIDOCAINE PRILOCAINE SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LIDOCAINE PRILOCAINE SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PRILOCAINE CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PRILOCAINE CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 144. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 145. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 146. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 147. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 148. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 149. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 150. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 151. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 152. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 153. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 154. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 155. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2018-2024 (USD MILLION)
TABLE 156. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2025-2030 (USD MILLION)
TABLE 157. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 158. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 159. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
TABLE 160. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
TABLE 161. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 164. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 165. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 168. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 172. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 173. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 174. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 175. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 182. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 183. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 188. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFF LABEL SSRIS, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 287. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 288. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 289. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 290. G

Samples

Loading
LOADING...

Companies Mentioned

  • Menarini Group
  • Teva Pharmaceuticals Industries Ltd.
  • Cipla Limited
  • Lupin Limited
  • Sun Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Panacea Biotec Ltd.
  • Endo International plc
  • Reckitt Benckiser Group plc
  • Bayer AG

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.78 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Premature Ejaculation Treatment - Global Strategic Business Report - Product Image

Premature Ejaculation Treatment - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Premature Ejaculation Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Premature Ejaculation Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 181 Pages
  • Global
From
Premature Ejaculation Treatment Market Report 2025 - Product Image

Premature Ejaculation Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Premature Ejaculation Epidemiology Forecast 2025-2034 - Product Image

Premature Ejaculation Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Premature Ejaculation Treatment Market 2025-2029 - Product Image

Premature Ejaculation Treatment Market 2025-2029

  • Report
  • 201 Pages
  • Global
From

About the Premature Ejaculation Drug Market

The Premature Ejaculation Drug market is a subset of the Sexual and Reproductive Health Drugs market. It is composed of drugs used to treat premature ejaculation, a condition in which a man ejaculates too quickly during sexual intercourse. These drugs are typically taken orally and work by increasing the time it takes for a man to ejaculate. Common side effects of these drugs include dizziness, headache, and nausea. The Premature Ejaculation Drug market is growing due to increased awareness of the condition and the availability of treatments. This has led to an increase in demand for these drugs, as well as an increase in research and development of new drugs. Some companies in the Premature Ejaculation Drug market include Pfizer, Eli Lilly, and Johnson & Johnson. These companies are involved in the research, development, and marketing of drugs to treat premature ejaculation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.